NeuroBo Pharmaceuticals Inc (NRBO)
2.39
-0.17
(-6.64%)
USD |
NASDAQ |
Nov 14, 16:00
2.37
-0.02
(-0.84%)
After-Hours: 20:00
NeuroBo Pharmaceuticals Cash and Short Term Investments (Quarterly): 21.67M for Sept. 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 21.67M |
June 30, 2024 | 27.93M |
March 31, 2024 | 15.99M |
December 31, 2023 | 22.44M |
September 30, 2023 | 25.84M |
June 30, 2023 | 28.69M |
March 31, 2023 | 30.81M |
December 31, 2022 | 33.36M |
September 30, 2022 | 6.356M |
June 30, 2022 | 8.849M |
March 31, 2022 | 11.56M |
December 31, 2021 | 16.39M |
September 30, 2021 | 6.984M |
June 30, 2021 | 9.513M |
March 31, 2021 | 13.04M |
December 31, 2020 | 10.09M |
September 30, 2020 | 12.35M |
June 30, 2020 | 14.30M |
Date | Value |
---|---|
March 31, 2020 | 9.799M |
December 31, 2019 | 13.91M |
September 30, 2019 | 1.855M |
June 30, 2019 | 3.643M |
March 31, 2019 | 5.51M |
December 31, 2018 | 2.845M |
September 30, 2018 | 23.81M |
June 30, 2018 | 28.04M |
March 31, 2018 | 34.46M |
December 31, 2017 | 18.47M |
September 30, 2017 | 25.34M |
June 30, 2017 | 22.49M |
March 31, 2017 | 29.28M |
December 31, 2016 | 24.03M |
September 30, 2016 | 28.37M |
June 30, 2016 | 4.826M |
March 31, 2016 | 1.629M |
December 31, 2015 | 3.62M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
6.356M
Minimum
Sep 2022
33.36M
Maximum
Dec 2022
16.99M
Average
14.10M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
Cytokinetics Inc | 1.012B |
Ocugen Inc | 38.70M |
enVVeno Medical Corp | 48.38M |
Scholar Rock Holding Corp | 190.49M |
Mirum Pharmaceuticals Inc | 278.37M |